文献速递艾滋病与性传播感染

实现90-90-90目标不足以达成澳大利亚HIV发病率下降目标

Achieving 90-90-90 Human Immunodeficiency Virus (HIV) Targets Will Not Be Enough to Achieve the HIV Incidence Reduction Target in Australia.
PubMed 文献 · Clin Infect Dis · 2018-01-01

该数学建模研究评估澳大利亚在不同检测、预防和PrEP扩大覆盖下实现UNAIDS 90-90-90及95-95-95目标对HIV发病率的影响。结果显示仅实现90-90-90至2020年可使发病率较2010年下降10%,实现95-95-95至2030年下降17%,即使叠加PrEP和 condom 使用扩大也仅达45%,极端假设下最多下降80%,均未达90%目标。

要点

  • 实现90-90-90仅使HIV发病率较2010年下降10%,远低于90%目标。
  • 实现95-95-95并扩大PrEP至30%高危MSM覆盖及condom使用至60%仅下降45%。
  • 即使95-95-95叠加100%PrEP覆盖和100%condom使用,2030年发病率仅下降80%。

核心结论

  • 许多国家尤其是低HIV流行国家即使实现UNAIDS目标也难以在2030年达成HIV发病率下降90%。
  • 需要大幅提高预防覆盖水平和检测频率才能接近该目标。

研究设计与样本

  • 数学建模研究,评估澳大利亚实现90-90-90(2020年)和95-95-95(2030年)目标联合不同检测、一级预防和PrEP扩大对HIV发病率的影响。

主要发现

  • 2020年实现90-90-90预计使发病率较2010年下降10%。
  • 2030年实现95-95-95预计使发病率较2010年下降17%。
  • 将PrEP扩大5年至高危MSM 30%覆盖率可使发病率下降至34%。
  • 同时将MSM condom使用率从42%提高至60%可使发病率下降至45%。
  • 即使实现95-95-95、低危MSM每年2次检测、高危MSM每年4次检测、高危MSM 100%PrEP覆盖和100%condom使用,2030年发病率仅下降80%。

关键数值与推荐

  • 90-90-90目标对应2020年,95-95-95目标对应2030年,发病率下降目标为较2010年下降90%。
  • 低危MSM每年检测2次、高危MSM每年检测4次可实现第一个95。
  • PrEP扩大至高危MSM 30%覆盖率,condom使用率从42%提高至60%。

临床怎么用

  • 仅依赖治疗目标不足以显著降低HIV发病率,需同步扩大检测频率、PrEP和condom使用等综合预防措施。
  • 低HIV流行国家应设定高于UNAIDS目标的预防覆盖和检测频率以追求发病率下降目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We estimated the human immunodeficiency virus (HIV) incidence reduction in Australia that would correspond to achieving the United Nations Program on HIV and AIDS (UNAIDS) 90-90-90 targets by 2020 and extended targets of 95-95-95 by 2030. This was done in combination with various scale-ups of HIV testing, primary prevention, and preexposure prophylaxis (PrEP) among high-risk men who have sex with men (MSM). These projections were evaluated against the target of achieving a 90% reduction in HIV incidence by 2030 compared with 2010 levels. METHODS: A mathematical model. RESULTS: Achieving 90-90-90 by 2020 was estimated to reduce incidence by 10% from 2010 levels. Achieving 95-95-95 by 2030 was estimated to reduce incidence by 17% from 2010 levels, with the first "95" being achievable by testing low- and high-risk MSM 2 and 4 times per year, respectively. This was improved to a 34% reduction by including a 5-year scale-up of PrEP to 30% coverage among high-risk MSM and to 45% by also increasing MSM condom use from 42% to 60%. However, even with 95-95-95, 2 and 4 tests per year for low- and high-risk MSM, 100% high-risk MSM PrEP coverage, and 100% MSM condom use, only an 80% reduction in incidence was possible by 2030. CONCLUSIONS: Many countries, particularly those with low HIV prevalence, will struggle to achieve a 90% reduction in HIV incidence by 2030, even if UNAIDS targets are met. Most will require substantially higher levels of prevention coverage and higher testing frequencies to reach this target.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Scott N, Stoové M, Kelly SL, et al. Achieving 90-90-90 Human Immunodeficiency Virus (HIV) Targets Will Not Be Enough to Achieve the HIV Incidence Reduction Target in Australia. Clin Infect Dis. 2018. PMID: 29099920. doi:10.1093/cid/cix939

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。